- Nov 21, 2018
Scientists develop potential new treatment for common soft-tissue childhood cancer
Scientists have developed a potential new therapeutic approach for synovial sarcoma, one of the most common soft-tissue cancers in teenagers and young adults. Read more: https://eurekalert.org/pub_releases/2018-11/tcd-sdp112018.php
- Nov 15, 2018
Clinical trial harnesses power of natural killer cells to treat neuroblastoma
Now for the first time, scientists will combine NK cell therapy with an immunocytokine to target children with relapsed/refractory neuroblastoma including those with bulky tumors. Read more: https://www.eurekalert.org/pub_releases/2018-11/skc-cth111418.php
- Nov 15, 2018
Drug combination makes cancer disappear in mice with neuroblastoma
Researchers investigating new treatments for neuroblastoma - one of the most common childhood cancers - have found that a combination of two drugs made tumours disappear in mice, making it more effective than any other drugs tested in these animals. Read more: https://www.eurekalert.org/pub_releases/2018-11/eeco-dcm111318.php
- Nov 8, 2018
Tiny molecule has big effect in childhood brain tumor studies
A very small molecule under study is able to kill a childhood brain cancer, and the lead researcher said it may be possible to reduce by 90 percent the amount of chemotherapy and radiation required to kill such tumors. Read more: https://www.sciencedaily.com/releases/2018/11/181107133805.htm
- Nov 7, 2018
Study: Proton therapy better than radiation for children's brain tumors
Children with brain tumors had better neurocognitive outcomes with proton therapy treatment compared with X-ray radiation therapy, according to a study. Read more: https://www.upi.com/Health_News/2018/11/06/Study-Proton-therapy-better-than-radiation-for-childrens-brain-tumors/5701541520421/
- Nov 2, 2018
Breakthrough in childhood brain cancer
Scientists led by Newcastle University have been able to identify the group of children needing more intensive, aggressive chemotherapy treatment for the most common form of brain cancer. Read more: https://medicalxpress.com/news/2018-11-breakthrough-childhood-brain-cancer.html
- Nov 1, 2018
UA targeting rhabdomyosarcoma, a rare pediatric cancer with few treatment options
Rhabdomyosarcoma (RMS) is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of 4 patients are cured with standard treatment. Survival rates drop to 17 percent if the disease comes back (recurs) and to 30 percent if it spreads (metastasizes). Read more: https://www.eurekalert.org/pub_releases/2018-10/uoah-utr103118.php
- Nov 1, 2018
'We're sorry you're here, but we are here' : Ontario Parents Advocating for Children
Article on OPACC's Hamilton childhood cancer parent support group Read more: https://www.hamiltonnews.com/community-story/9001137--we-re-sorry-you-re-here-but-we-are-here-ontario-parents-advocating-for-children-with-cancer/